rolipram and morphine
rolipram has been researched along with morphine in 11 studies
Research
Studies (11)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Nicholson, D; Sawynok, J; White, TD | 1 |
Mulder, AH; Schoffelmeer, AN; Wierenga, EA | 1 |
Baba, J; Ichimaru, Y; Mori, T; Suzuki, T | 1 |
Furukawa, S; Hamdy, M; Kameyama, T; Mamiya, T; Nabeshima, T; Noda, Y; Ren, X; Yamada, K | 1 |
Cherry, JA; Kantak, KM; Sachs, BD; Thompson, BE | 1 |
Abe, K; Inoue, O; Itoh, T; Kimura, M; Tokumura, M | 1 |
Mizuno, T; Nabeshima, T; Nakajima, A; Nitta, A; Yamada, K; Yan, Y | 1 |
González-Cuello, A; Laorden, ML; Milanés, MV; Núñez, C; Sánchez, L; Vargas, ML | 1 |
Haji, A; Kimura, S; Ohi, Y | 1 |
Chen, WY; Jeng, MJ; Lee, YS; Lin, CH; Tsao, PC | 1 |
Other Studies
11 other study(ies) available for rolipram and morphine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 5'-Nucleotidase; Adenosine; Animals; Colforsin; Cyclic AMP; In Vitro Techniques; Morphine; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rolipram; Spinal Cord; Synaptosomes | 1991 |
Role of adenylate cyclase in presynaptic alpha 2-adrenoceptor- and mu-opioid receptor-mediated inhibition of [3H]noradrenaline release from rat brain cortex slices.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Animals; Bucladesine; Cadmium; Calcimycin; Cerebral Cortex; Clonidine; Colforsin; Cyclic AMP; Electric Stimulation; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Morphine; Norepinephrine; Phentolamine; Pyrrolidinones; Rats; Receptors, Adrenergic, alpha; Receptors, Opioid; Receptors, Opioid, mu; Rolipram | 1986 |
Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Benzazepines; Cyclic Nucleotide Phosphodiesterases, Type 4; Dopamine Agents; Locomotion; Male; Methamphetamine; Mice; Morphine; Phencyclidine; Phosphodiesterase Inhibitors; Rolipram | 2000 |
Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cerebral Cortex; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Male; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Pain Measurement; Phosphodiesterase Inhibitors; Rolipram; Substance Withdrawal Syndrome; Thalamus | 2001 |
The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Basal Ganglia; Cell Count; Cocaine; Conditioning, Operant; Cyclic Nucleotide Phosphodiesterases, Type 4; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Male; Mice; Morphine; Phosphodiesterase Inhibitors; Proto-Oncogene Proteins c-fos; Rolipram; Transcriptional Activation | 2004 |
Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Brain; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Activation; Male; Morphine; Naloxone; Rats; Rats, Sprague-Dawley; Rolipram; Substance Withdrawal Syndrome | 2006 |
Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds.
Topics: Analysis of Variance; Animals; Calcium Channel Blockers; Central Nervous System Agents; Central Nervous System Stimulants; Cyclic AMP; Discrimination Learning; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Male; Methamphetamine; Morphine; Narcotics; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram; Second Messenger Systems; Signal Transduction | 2006 |
Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
Topics: Adaptation, Physiological; Animals; Cyclic AMP; Cyclic GMP; Diazepam; Gene Expression Regulation; Male; Morphine; Neurosecretory Systems; Norepinephrine; Paraventricular Hypothalamic Nucleus; Phosphodiesterase Inhibitors; Pituitary Gland; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rolipram; Substance Withdrawal Syndrome | 2009 |
Blockade of phosphodiesterase 4 reverses morphine-induced ventilatory disturbance without loss of analgesia.
Topics: Analgesics, Opioid; Animals; Caffeine; Male; Morphine; Pain Measurement; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Phrenic Nerve; Rats; Rats, Wistar; Respiration Disorders; Respiratory Mechanics; Rolipram; Vagotomy | 2015 |
Pathophysiological effects of intravenous phosphodiesterase type 4 inhibitor in addition to surfactant lavage in meconium-injured newborn piglet lungs.
Topics: Administration, Intravenous; Animals; Animals, Newborn; Bronchoalveolar Lavage; Combined Modality Therapy; Humans; Lung; Lung Compliance; Meconium; Meconium Aspiration Syndrome; Phosphodiesterase 4 Inhibitors; Rolipram; Surface-Active Agents; Swine; Tachycardia | 2020 |